Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules

PHILADELPHIA, June 18, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, the therapeutic equivalent to the ... Biopharmaceuticals, Generics Lannett Company, Aggrenox, Dipyridamole, Boehringer Ingelheim
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news